Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
Autoimmune Disorders01:29

Autoimmune Disorders

366
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
366
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

219
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
219
Factors Affecting Illness01:18

Factors Affecting Illness

4.1K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
4.1K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

23
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
23
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

20
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
20

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.

Nature medicine·2026
Same author

Thirty-Year Trends in Multiple Sclerosis Prevalence, Lifestyle Factors, and Mortality in England.

JAMA neurology·2026
Same author

Neuronal plasticity during motor rehabilitation training after spinal cord injury.

Communications biology·2026
Same author

Paediatric cerebrospinal fluid immune profiling distinguishes paediatric-onset multiple sclerosis from other paediatric-onset acute neurological disorders.

EBioMedicine·2026
Same author

Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial.

JCI insight·2025
Same author

Depression as a Disease of White Matter Network Disruption: Learning From Multiple Sclerosis.

Biological psychiatry·2025

Related Experiment Video

Updated: May 21, 2025

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

734

Multiple sclerosis and COVID-19: interactions and unresolved issues.

Ana Zabalza1, Alan Thompson2, Dalia L Rotstein3

  • 1Servei de Neurologia and Centre d'Esclerosi Múltiple de Catalunya, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain.

The Lancet. Neurology
|March 22, 2025
PubMed
Summary

People with multiple sclerosis (MS) face serious risks from SARS-CoV-2 infection. Optimizing vaccines and therapies is crucial for managing COVID-19 in MS patients, especially those on immunosuppressants.

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.4K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.2K

Related Experiment Videos

Last Updated: May 21, 2025

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

734
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.4K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.2K

Area of Science:

  • Neurology
  • Immunology
  • Infectious Diseases

Background:

  • Multiple sclerosis (MS) patients, particularly those on immunosuppressants, are at increased risk for severe SARS-CoV-2 infection and COVID-19 complications.
  • Understanding the interaction between SARS-CoV-2 and MS is vital for patient management.

Purpose of the Study:

  • To review current knowledge on SARS-CoV-2 infection in MS.
  • To discuss immunological responses to infection and vaccination in MS.
  • To highlight challenges and future directions in managing COVID-19 in MS patients.

Main Methods:

  • Literature review of studies on SARS-CoV-2 in multiple sclerosis.
  • Analysis of immunological responses to infection and vaccination.
  • Evaluation of current and emerging therapeutic strategies.

Main Results:

  • MS patients on immunosuppressive therapies are a high-risk group for severe COVID-19.
  • Immunological responses to SARS-CoV-2 infection and vaccines in MS vary.
  • Evolving SARS-CoV-2 variants necessitate updated clinical guidance.

Conclusions:

  • Clinical neurologists require regular updates on SARS-CoV-2 management in MS.
  • Optimizing vaccination strategies and managing non-responders are key challenges.
  • Future research should focus on novel therapies, preventive measures, and variant tracking for pandemic preparedness.